$2.87 Billion is the total value of Bank Pictet & Cie (Europe) AG's 268 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| VAL | New | VALARIS LTDcl a | $27,063,431 | – | 360,942 | +100.0% | 0.94% | – |
| TEVA | New | TEVA PHARMACEUTICAL INDS LTDsponsored ads | $13,770,000 | – | 1,350,000 | +100.0% | 0.48% | – |
| SPGI | New | S&P GLOBAL INC | $8,447,548 | – | 23,118 | +100.0% | 0.29% | – |
| RIO | New | RIO TINTO PLCsponsored adr | $4,197,503 | – | 65,957 | +100.0% | 0.15% | – |
| New | CRH PLCord | $2,916,343 | – | 53,286 | +100.0% | 0.10% | – | |
| GOLD | New | BARRICK GOLD CORP | $1,129,095 | – | 77,601 | +100.0% | 0.04% | – |
| NEE | New | NEXTERA ENERGY INC | $374,104 | – | 6,530 | +100.0% | 0.01% | – |
| XOM | New | EXXON MOBIL CORP | $373,317 | – | 3,175 | +100.0% | 0.01% | – |
| WST | New | WEST PHARMACEUTICAL SVSC INC | $349,321 | – | 931 | +100.0% | 0.01% | – |
| RGEN | New | REPLIGEN CORP | $342,349 | – | 2,153 | +100.0% | 0.01% | – |
| GMED | New | GLOBUS MED INCcl a | $282,409 | – | 5,688 | +100.0% | 0.01% | – |
| New | APOLLO GLOBAL MGMT INC | $224,400 | – | 2,500 | +100.0% | 0.01% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-02
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| DISNEY WALT CO | 40 | Q3 2023 | 4.6% |
| LYONDELLBASELL INDUSTRIES N | 40 | Q3 2023 | 2.2% |
| ADOBE SYSTEMS INCORPORATED | 40 | Q3 2023 | 0.7% |
| AMAZON COM INC | 39 | Q3 2023 | 9.8% |
| MICROSOFT CORP | 39 | Q3 2023 | 8.0% |
| SPDR S&P 500 ETF TR | 39 | Q3 2023 | 9.7% |
| APPLE INC | 39 | Q3 2023 | 6.1% |
| PEPSICO INC | 39 | Q3 2023 | 4.3% |
| UNITEDHEALTH GROUP INC | 39 | Q3 2023 | 6.1% |
| DANAHER CORPORATION | 39 | Q3 2023 | 3.6% |
View Bank Pictet & Cie (Europe) AG's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| 3SBio Inc. | February 22, 2012 | 1,297,442 | 5.9% |
| OPTIMER PHARMACEUTICALS INC | February 22, 2012 | 2 | 5.0% |
| PICTET & CIE EUROPE SA | August 04, 2011 | 2 | 4.9% |
| XENOPORT INC | April 20, 2011 | 1 | 4.8% |
| AMAG PHARMACEUTICALS INC. | February 22, 2011 | 1 | 6.5% |
| MEDIVATION, INC. | February 22, 2011 | 2 | 6.1% |
| MEDICINES CO /DE | October 08, 2010 | 1 | 4.6% |
| MEDICINES CO /DE | March 11, 2010 | 2,628,695 | 5.0% |
| INTERMUNE INC | February 19, 2010 | 2 | 5.0% |
| AUXILIUM PHARMACEUTICALS INC | October 28, 2009 | 2 | 5.0% |
View Bank Pictet & Cie (Europe) AG's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-09 |
| 13F-HR | 2023-11-02 |
| 13F-HR | 2023-08-08 |
| 13F-HR | 2023-05-01 |
| 13F-HR | 2023-02-08 |
| 13F-HR | 2022-11-10 |
| 13F-HR | 2022-08-05 |
| 13F-HR | 2022-05-04 |
| 13F-HR | 2022-02-02 |
| 13F-HR/A | 2021-11-12 |
View Bank Pictet & Cie (Europe) AG's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.